Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH
Management Tips: Start with a lower dose as prescribed to allow your body to adjust
And humans that have connection, whether it's to themselves, it's to the higher power, it's to their family, you know, it's to their community, live longer
Some patients report that injecting before breakfast creates a psychological advantage, as the appetite suppression kicks in throughout the day when food temptations are highest
Pessayre D, Dolder A, Artigou JY, Wandscheer JC, Descatoire V, Degott C & Benhamou JP (1979): Effect of fasting on metabolite-mediated hepatotoxicity in the rat
By cutting out the middleman, we have full control over the quality and integrity of our products, allowing us to ensure the highest standards of safety and efficacy while passing on cost savings to you
